153 related articles for article (PubMed ID: 33344248)
1. A Nomogram Predicts Individual Prognosis in Patients With Newly Diagnosed Glioblastoma by Integrating the Extent of Resection of Non-Enhancing Tumors.
Zhang Z; Jin Z; Liu D; Zhang Y; Li C; Miao Y; Chi X; Feng J; Wang Y; Hao S; Ji N
Front Oncol; 2020; 10():598965. PubMed ID: 33344248
[TBL] [Abstract][Full Text] [Related]
2. An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825.
Gittleman H; Lim D; Kattan MW; Chakravarti A; Gilbert MR; Lassman AB; Lo SS; Machtay M; Sloan AE; Sulman EP; Tian D; Vogelbaum MA; Wang TJC; Penas-Prado M; Youssef E; Blumenthal DT; Zhang P; Mehta MP; Barnholtz-Sloan JS
Neuro Oncol; 2017 May; 19(5):669-677. PubMed ID: 28453749
[TBL] [Abstract][Full Text] [Related]
3. An independently validated nomogram for isocitrate dehydrogenase-wild-type glioblastoma patient survival.
Gittleman H; Cioffi G; Chunduru P; Molinaro AM; Berger MS; Sloan AE; Barnholtz-Sloan JS
Neurooncol Adv; 2019; 1(1):vdz007. PubMed ID: 31608326
[TBL] [Abstract][Full Text] [Related]
4. Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma.
Molinaro AM; Hervey-Jumper S; Morshed RA; Young J; Han SJ; Chunduru P; Zhang Y; Phillips JJ; Shai A; Lafontaine M; Crane J; Chandra A; Flanigan P; Jahangiri A; Cioffi G; Ostrom Q; Anderson JE; Badve C; Barnholtz-Sloan J; Sloan AE; Erickson BJ; Decker PA; Kosel ML; LaChance D; Eckel-Passow J; Jenkins R; Villanueva-Meyer J; Rice T; Wrensch M; Wiencke JK; Oberheim Bush NA; Taylor J; Butowski N; Prados M; Clarke J; Chang S; Chang E; Aghi M; Theodosopoulos P; McDermott M; Berger MS
JAMA Oncol; 2020 Apr; 6(4):495-503. PubMed ID: 32027343
[TBL] [Abstract][Full Text] [Related]
5. Prognostic analysis and nomogram construction for older patients with IDH-wild-type glioblastoma.
Cao W; Xiong L; Meng L; Li Z; Hu Z; Lei H; Wu J; Song T; Liu C; Wei R; Shen L; Hong J
Heliyon; 2023 Jul; 9(7):e18310. PubMed ID: 37519736
[TBL] [Abstract][Full Text] [Related]
6. The Association Between the Extent of Glioblastoma Resection and Survival in Light of MGMT Promoter Methylation in 326 Patients With Newly Diagnosed IDH-Wildtype Glioblastoma.
Incekara F; Smits M; van der Voort SR; Dubbink HJ; Atmodimedjo PN; Kros JM; Vincent AJPE; van den Bent M
Front Oncol; 2020; 10():1087. PubMed ID: 32766140
[No Abstract] [Full Text] [Related]
7. Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.
Grabowski MM; Recinos PF; Nowacki AS; Schroeder JL; Angelov L; Barnett GH; Vogelbaum MA
J Neurosurg; 2014 Nov; 121(5):1115-23. PubMed ID: 25192475
[TBL] [Abstract][Full Text] [Related]
8. Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.
Gorlia T; van den Bent MJ; Hegi ME; Mirimanoff RO; Weller M; Cairncross JG; Eisenhauer E; Belanger K; Brandes AA; Allgeier A; Lacombe D; Stupp R
Lancet Oncol; 2008 Jan; 9(1):29-38. PubMed ID: 18082451
[TBL] [Abstract][Full Text] [Related]
9. Determining a cut-off residual tumor volume threshold for patients with newly diagnosed glioblastoma treated with temozolomide chemoradiotherapy: A multicenter cohort study.
Woo PYM; Ho JMK; Tse TPK; Lam SW; Mak CHK; Chan DTM; Lee MWY; Wong ST; Chan KY; Poon WS
J Clin Neurosci; 2019 May; 63():134-141. PubMed ID: 30712777
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of nomograms to accurately predict risk of recurrence for patients with laryngeal squamous cell carcinoma: Cohort study.
Cui J; Wang L; Tan G; Chen W; He G; Huang H; Chen Z; Yang H; Chen J; Liu G
Int J Surg; 2020 Apr; 76():163-170. PubMed ID: 32173614
[TBL] [Abstract][Full Text] [Related]
11. Prognosis viewing for nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: application of nomogram and decision curve analysis.
Fei Z; Qiu X; Li M; Chen C; Li Y; Huang Y
Jpn J Clin Oncol; 2020 Feb; 50(2):159-168. PubMed ID: 31711182
[TBL] [Abstract][Full Text] [Related]
12. Development and external validation of a prognostic nomogram for acute decompensation of chronic hepatitis B cirrhosis.
Gao F; Li X; Wan G; Li Y; Zhang Q; Liu Y; Liu H; Li H; Wang X
BMC Gastroenterol; 2018 Dec; 18(1):179. PubMed ID: 30509201
[TBL] [Abstract][Full Text] [Related]
13. A nomogram for individualized prediction of overall survival in patients with newly diagnosed glioblastoma: a real-world retrospective cohort study.
Kudulaiti N; Zhou Z; Luo C; Zhang J; Zhu F; Wu J
BMC Surg; 2021 May; 21(1):238. PubMed ID: 33957923
[TBL] [Abstract][Full Text] [Related]
14. An independently validated survival nomogram for lower-grade glioma.
Gittleman H; Sloan AE; Barnholtz-Sloan JS
Neuro Oncol; 2020 May; 22(5):665-674. PubMed ID: 31621885
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a prognostic nomogram for acute-on-chronic hepatitis B liver failure.
Shi KQ; Cai YJ; Lin Z; Dong JZ; Wu JM; Wang XD; Song M; Wang YQ; Chen YP
J Gastroenterol Hepatol; 2017 Feb; 32(2):497-505. PubMed ID: 27490495
[TBL] [Abstract][Full Text] [Related]
16. Nomogram to predict overall survival after gallbladder cancer resection in China.
Bai Y; Liu ZS; Xiong JP; Xu WY; Lin JZ; Long JY; Miao F; Huang HC; Wan XS; Zhao HT
World J Gastroenterol; 2018 Dec; 24(45):5167-5178. PubMed ID: 30568393
[TBL] [Abstract][Full Text] [Related]
17. A nomogram predicting overall survival in patients with non-metastatic pancreatic head adenocarcinoma after surgery: a population-based study.
Zou W; Wang Z; Wang F; Zhang G; Liu R
BMC Cancer; 2021 May; 21(1):524. PubMed ID: 33964898
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a prognostic nomogram for predicting overall survival in patients with primary bladder sarcoma: a SEER-based retrospective study.
Li S; Liu X; Chen X
BMC Urol; 2021 Nov; 21(1):162. PubMed ID: 34823525
[TBL] [Abstract][Full Text] [Related]
19. Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma.
Ge D; Luo Z; Mao R; Zhao H; Lv X; Zhao J; Zhou J; Huang Z; Zhang Y; Li Z; Bi X; Cai J
Adv Ther; 2020 Jul; 37(7):3185-3205. PubMed ID: 32436026
[TBL] [Abstract][Full Text] [Related]
20. [Establishment and validation of a nomogram to predict overall survival of patients with gastric neuroendocrine neoplasms].
Wang YL; Guo Y; Zhang RH; Chen LH; Yang YJ; Wang W; Chen J; Zhou ZW
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):883-888. PubMed ID: 34674463
[No Abstract] [Full Text] [Related]
[Next] [New Search]